Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells
Fig 5
Anti-proliferative effect of YC in combination with gefitinib or rapamycin in H1993 cells.
The cells were treated with YC alone or in combination with gefitinib or rapamycin for 48 h. The cell proliferation was measured using a SRB assay. (A) YC in combination with gefitinib (B) YC in combination with rapamycin.